Ceftriaxone sodium has a strong effect on Escherichia coli, Pneumococcus, Indole-positive Proteus, Influenza Bacillus, Serratia, Meningococcus, Neisseria gonorrhoeae; Pneumococcus, Streptococcus and Staphylococcus aureus have moderate effects on this product Sensitive; has a certain effect on Pseudomonas aeruginosa, Enterococcus, Methicillin-resistant Staphylococcus and most Bacteroides fragilis are resistant to this product.
Reyoung pharmaceutical CO.,LTD was established in 1966, is a modern comprehensive pharmaceutical company in China. Reyoung is given the title of National Trustworthy Company for Contract and Credit, Grade AAA Credit Company and Credit Company of Shandong Medical Industry. In the past 50 years, Reyoung inherits the mission Reyoung Pharma, Benefit the public, never stop exploration and innovation, forging ahead with determination and realizing the sustainable healthy development.
Now Reyoung consists of 3 factory sites, covering an area of 1 million square meter , possessing more than 30 workshops(9 categories, and 400 strengths) , focusing on developing , manufacturing and selling Powder for injection(Lyophilized powder for injection is included), Small volume injection, Traditional Chinese Medicine, Tablets, Capsules, Granules, Suppository, Mixtures and APIs.
All the workshops have been passed the Chinese GMP. Reyoung also passed the foreign audit including PIC/S GMP, Ethiopia, Uganda, Kenya, TFDA, NAFDAC, Ghana, Cote d'loire, Pakistan ect. Reyoung focus on the domestic and foreign market. Reyoung processes professional marketing teams, more than 160 representative offices spreading all over China. We commenced international business from 1997, and Reyoung products sell to more than 70 countries and NGOs all over the world.
Audited Supplier 
){kind=link}